Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

A novel mouse model of chronic Pseudomonas aeruginosa infection inducing bronchiectasis-like phenotype.

Animal models and experimental medicine·2026
Same author

Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies.

The European respiratory journal·2026
Same author

Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials.

American journal of respiratory and critical care medicine·2026
Same author

Development of an artificial intelligence prediction model for moderate-to-severe COPD exacerbations using continuous multiple unobtrusive sensors: protocol of a multicentre prospective observational study.

BMJ open respiratory research·2026
Same author

Association of German Bronchiectasis Registry participation with disease course.

ERJ open research·2026

Related Experiment Video

Updated: Jun 9, 2025

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

15.8K

Targeting neutrophil serine proteases in bronchiectasis.

James D Chalmers1,2, Marcus A Mall3,4,5,2, Sanjay H Chotirmall6,7

  • 1Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK.

The European Respiratory Journal
|October 28, 2024
PubMed
Summary

Persistent neutrophilic inflammation drives bronchiectasis progression. Inhibiting cathepsin C (CatC) may restore protease balance and improve outcomes, offering a promising new therapeutic strategy for this lung disease.

More Related Videos

Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics
07:37

Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics

Published on: June 7, 2018

6.4K
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.7K

Related Experiment Videos

Last Updated: Jun 9, 2025

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
09:23

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples

Published on: May 21, 2021

15.8K
Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics
07:37

Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics

Published on: June 7, 2018

6.4K
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.7K

Area of Science:

  • Pulmonology
  • Inflammation Research
  • Drug Development

Background:

  • Persistent neutrophilic inflammation is key in bronchiectasis pathogenesis and progression.
  • Neutrophil serine proteases (NSPs) cause lung damage when their activity overwhelms antiproteases.
  • Current treatments for neutrophilic inflammation in bronchiectasis are lacking.

Purpose of the Study:

  • To review the role of NSPs in bronchiectasis.
  • To discuss therapeutic strategies targeting neutrophilic inflammation.
  • To evaluate the potential of cathepsin C (CatC) inhibition.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of the role of NSPs in bronchiectasis pathology.
  • Summary of clinical trial outcomes for CatC inhibitors.

Main Results:

  • High NSP activity contributes to lung destruction, infection susceptibility, and poor outcomes in bronchiectasis.
  • Direct NE inhibition has been unsuccessful.
  • CatC inhibition shows promise by reducing multiple NSPs and restoring protease-antiprotease balance.

Conclusions:

  • CatC inhibition represents a promising therapeutic approach for bronchiectasis.
  • Positive Phase III clinical trial results support CatC inhibitors.
  • Further strategies are needed to effectively manage chronic neutrophilic inflammation in bronchiectasis.